The UK government should fund specialized trauma care for asylum seekers

Debate continues over whether uk government fund specialized trauma care for asylum see....

Overview Debates Related claims Topics Sources

Younger patients should receive priority when lifesaving treatment is scarce

Insurers should be barred from setting premiums using genetic tests

Publicly funded healthcare should cover infertility treatment

Medicare for All is a viable solution to the U.S. healthcare crisis

Medicare coverage of anti-obesity drugs would add about $35 billion to federal spending from 2026 to 2034

Semaglutide carries a regulator-confirmed risk of NAION, a very rare optic nerve condition

Semaglutide and tirzepatide are cost-effective for obesity at current net prices

Most adults with obesity but without diabetes stop GLP-1 drugs within a year

Medicare coverage of weight-loss drugs could save Medicare $175–245 billion over ten years

Canada should exclude mental illness as a sole condition for medically assisted dying

Governments should license publicly funded drug patents to competitors when prices are unaffordable

Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Approximately one in six Americans take an antidepressant medication, and average duration of use has surpassed five years.

Outro's deprescribing platform incorporates personalized hyperbolic tapering plans, compounded medication doses, patient monitoring, and specially-trained clinicians.

Outro plans to expand its tapering model into additional medication classes beyond antidepressants, including benzodiazepines, gabapentinoids, and GLP-1s.

Research led by Dr. Mark Horowitz found that four in five long-term antidepressant users were unable to stop taking their medications due to withdrawal symptoms.

Hyperbolic tapering is the most effective protocol for discontinuing psychiatric medications

Commercial digital platforms are suitable for managing complex psychiatric drug withdrawal

U.S. healthcare providers should prioritize deprescribing over long-term psychiatric medication maintenance

FDA approval standards based on short-term trials adequately protect long-term antidepressant users